Our system is currently under heavy load due to increased usage. We're actively working on upgrades to improve performance. Thank you for your patience.
2021
DOI: 10.7589/jwd-d-20-00001
|View full text |Cite
|
Sign up to set email alerts
|

The Effect of Maternal Antibodies on Clinical Response to Infection with Epizootic Hemorrhagic Disease Virus in White-Tailed Deer (Odocoileus virginianus) Fawns

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
7
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 7 publications
(9 citation statements)
references
References 13 publications
0
7
0
Order By: Relevance
“…Previously, studies showed that maternally-derived neutralizing antibodies against EHDV were detectable in fawns until 17-18 weeks of age [75]. A recently developed WTD fawn challenge model addressed the question of whether such maternallyderived antibodies against EHDV are protective against challenge; in this study it was demonstrated that even low titers of maternal antibodies to EHDV-2 provided protection against clinical disease and greatly reduced levels of viremia following challenge with the homologous EHDV-2 serotype virus [72]. Finally, the WTD model was recently applied to vaccine discovery, enabling the evaluation of immunogenicity and efficacy induced by a novel subunit vaccine candidate comprised of the recombinant viral capsid VP2 protein of EHDV-2 [73].…”
Section: Wtd In Vivo Studiesmentioning
confidence: 84%
See 1 more Smart Citation
“…Previously, studies showed that maternally-derived neutralizing antibodies against EHDV were detectable in fawns until 17-18 weeks of age [75]. A recently developed WTD fawn challenge model addressed the question of whether such maternallyderived antibodies against EHDV are protective against challenge; in this study it was demonstrated that even low titers of maternal antibodies to EHDV-2 provided protection against clinical disease and greatly reduced levels of viremia following challenge with the homologous EHDV-2 serotype virus [72]. Finally, the WTD model was recently applied to vaccine discovery, enabling the evaluation of immunogenicity and efficacy induced by a novel subunit vaccine candidate comprised of the recombinant viral capsid VP2 protein of EHDV-2 [73].…”
Section: Wtd In Vivo Studiesmentioning
confidence: 84%
“…A well-defined animal model is a quintessential research tool for advancing knowledge of pathogen transmission and pathogenesis, and an absolute requirement for countermeasure discovery and development. Despite the inherent challenges of working with WTD in research settings, experimental infections in deer have provided insights into host susceptibility, pathogenesis, and immune responses since the initial determination that EHD was a viral disease [10,[64][65][66][67][68][69][70][71][72][73]). Recent advances using in vivo WTD studies include the determination that deer were susceptible to experimental challenge with the emerging serotype EHDV-6, and that the EHDV-6-infected animals presented with clinical signs, pathological abnormalities, and postmortem findings consistent with studies of other EHDV serotypes in WTD [71].…”
Section: Wtd In Vivo Studiesmentioning
confidence: 99%
“…The social and nutritional stresses of weaning are known to produce impaired immunocompetence in young ruminants, including cervids [ 37 ], and this period of high stress and immunocompromise coincides with the peak of the HD transmission season in late summer and early fall. Maternal antibodies to EHDV have been shown to reduce or prevent clinical HD in protected WTD fawns [ 11 ], but maternal antibody titers decline by around 4–5 months of age [ 33 , 38 ]. The concurrence of impaired immunocompetence due to weaning stress, increased infection pressure, and decay of maternal antibody titers likely explain the high proportion of EHDV/BTV-positive submissions from this age range.…”
Section: Discussionmentioning
confidence: 99%
“…EHDV-6 was first detected in the US in 2006 and has since become widespread [ 7 ]. In regions where multiple endemic serotypes circulate on an annual basis (e.g., southern Florida) [ 8 , 9 ], immunity acquired through previous infection and the passive transfer of maternal antibodies in native WTD populations may produce a state of enzootic stability [ 10 , 11 , 12 ]. In these regions, clinical disease is rare despite on-going exposure.…”
Section: Introductionmentioning
confidence: 99%
“…Maternally derived antibodies may help to prevent infection or reduce the severity of disease in fawns. For example, the presence of maternally derived antibodies to epizootic hemorrhagic disease virus (EHDV) serotype 2 in fawns prevented or significantly reduced clinical disease and length of viremia compared with that of naïve fawns challenged under experimental conditions (Stilwell et al 2021). Conversely, infection of a dam is likely to come at an energetic cost that may result in the birth of smaller fawns and compromise the dam's ability to rear young (Verme 1965; Ballard 2011).…”
Section: Introductionmentioning
confidence: 99%